Cytoplasmic phosphorylated ERK1/2 expression in patients with melanoma is associated with tumor stage and metastasis.

MLA

Tseng, Yen-Shuo, et al. “Cytoplasmic Phosphorylated ERK1/2 Expression in Patients with Melanoma Is Associated with Tumor Stage and Metastasis.” Biotechnic & Histochemistry, vol. 97, no. 2, Feb. 2022, pp. 118–25. EBSCOhost, https://doi.org/10.1080/10520295.2021.1912827.

APA

Tseng, Y.-S., Wu, P.-R., Lu, J.-W., Wang, Y.-F., Yeh, K.-T., & Lin, S.-H. (2022). Cytoplasmic phosphorylated ERK1/2 expression in patients with melanoma is associated with tumor stage and metastasis. Biotechnic & Histochemistry, 97(2), 118–125. https://doi.org/10.1080/10520295.2021.1912827

Chicago

Tseng, Yen-Shuo, Pei-Ru Wu, Jeng-Wei Lu, Yu-Fen Wang, Kun-Tu Yeh, and Shu-Hui Lin. 2022. “Cytoplasmic Phosphorylated ERK1/2 Expression in Patients with Melanoma Is Associated with Tumor Stage and Metastasis.” Biotechnic & Histochemistry 97 (2): 118–25. doi:10.1080/10520295.2021.1912827.